Martingale Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-139,858
| Closed | -$1.6M | – | 835 |
|
|
2023
Q4 | $1.6M | Sell |
139,858
-140
| -0.1% | -$1.6K | 0.03% | 339 |
|
|
2023
Q3 | $1.35M | Hold |
139,998
| – | – | 0.03% | 355 |
|
|
2023
Q2 | $1.49M | Buy |
139,998
+5,706
| +4% | +$60.7K | 0.03% | 342 |
|
|
2023
Q1 | $1.41M | Buy |
134,292
+2,702
| +2% | +$28.4K | 0.03% | 347 |
|
|
2022
Q4 | $1.63M | Buy |
131,590
+2,837
| +2% | +$35.2K | 0.03% | 316 |
|
|
2022
Q3 | $1.34M | Buy |
128,753
+3,703
| +3% | +$38.4K | 0.03% | 355 |
|
|
2022
Q2 | $1.44M | Buy |
125,050
+28,902
| +30% | +$334K | 0.03% | 361 |
|
|
2022
Q1 | $1.21M | Buy |
+96,148
| New | +$1.21M | 0.02% | 428 |
|